20130 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials; Organic macromolecular compounds Proteins, e.g. gelatin
MICROBIOME DELIVERY PLATFORM
#2COMPOSITIONS AND METHODS FOR TREATMENT OF IMMUNE CHECKPOINT RESISTANT CANCERS
#3TABLETS HAVING DISCONTINUOUS COATED REGIONS
#4TABLETS HAVING DISCONTINUOUS COATED REGIONS
#5MICROBIOME DELIVERY PLATFORM
#6COMPOSITIONS AND METHODS FOR TREATMENT OF IMMUNE CHECKPOINT RESISTANT CANCERS
#7Pharmaceutical compositions comprising coated API
#8Rapidly disintegrating gelatinous coated tablets
#9AGONISTS OF GUANYLATE CYCLASE AND THEIR USES
#10CONTROLLED RELEASE DOSAGE FORMS OF 5-AMINOSALICYLIC ACID AND PROCESS THEREOF
#11Beta-lactamase formulations and uses thereof
#12Enterically coated cysteamine, cystamine and derivatives thereof
#13Expandable drug delivery pill
#14Rapidly disintegrating gelatinous coated tablets
#15One kind of Live Bacteria Preparation of Bacillus Coagulans and Preparation Method thereof
#16Tablets having discontinuous coated regions
#17Fast dissolving tablet formulations and methods of making thereof
#18PHARMACEUTICAL COMPOSITION COMPRISING PANCREATIN AND A LIPASE-CONTAINING COATING
#19Agonists of guanylate cyclase and their uses
#20Expandable pill
#21DRUG DELIVERY SYSTEMS AND METHODS FOR PREPARATION THEREOF
#22CHEMICALLY CROSSLINKED PROTEIN-POLYSACCHARIDE COMPLEXED CONSUMABLE MACROCAPSULE
#23ORAL APPLICATION OF THIOPEPTCIN
#24Enterically coated cysteamine, cystamine and derivatives thereof
#25Tablets having discontinuous coated regions
#26Rapidly disintegrating gelatinous coated tablets
#27Beta-lactamase formulations and uses thereof
#28Fast dissolving tablet formulations and methods of making thereof
#29Delivery system comprising a core and a digestible polymer shell
#30GELATIN AND COMPRESSION BINDER FOR USE IN ORAL ADHERING DISCS
#31Oral pharmaceutical dosage form for the delivery of a peptide and/or protein
#32Pharmaceutical bead formulations comprising dimethyl fumarate
#33Enterically coated cysteamine, cystamine and derivatives thereof
#34Enterically coated cysteamine, cystamine and derivatives thereof
#35Enterically coated cysteamine, cystamine and derivatives thereof
#36Delivery system comprising a core and a digestible polymer shell
#37Agonists of guanylate cyclase and their uses
#38Non-digestible sugar-coated products and process
#39CARBIDOPA/LEVODOPA GASTRORETENTIVE DRUG DELIVERY
#40Enterically coated cysteamine, cystamine and derivatives thereof
#41Enterically coated cysteamine, cystamine and derivatives thereof
#42Enterically coated cysteamine, cystamine and derivatives thereof
#43Rotary die system
#44Beta-lactamase formulations and uses thereof
#45Rapidly disintegrating gelatinous coated tablets
#46Abuse resistant oral dosage forms
#47Rotary die system
#48Rapidly disintegrating gelatinous coated tablets
#49Chimeric surface active proteins
#50Abuse resistant oral dosage forms
#51ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#52Immediate release and sustained release ibuprofen dosing regimen
#53Method for manufacturing dosage forms
#54Enterically coated cysteamine, cystamine and derivatives thereof
#55Coating composition and use thereof
#56Surface active proteins as excipients in solid pharmaceutical formulations
#57Non-digestible sugar-coated products and process
#58RAPID-RELEASE ENCAPSULATION COMPOSITION
#59Carbidopa/Levodopa gastroretentive drug delivery
#60Rapidly disintegrating gelatinous coated tablets
#61Rapidly Disintegrating Dosage Form
#62NON-DIGESTIBLE SUGAR-COATED PRODUCTS AND PROCESS
#63METHOD OF MANUFACTURING MODIFIED RELEASE DOSAGE FORMS
#64Method of manufacturing modified release dosage forms
#65Alcohol Resistant Pharmaceutical Formulations
#66SYSTEM AND PROCESS FOR PROVIDING AT LEAST ONE OPENING IN DOSAGE FORMS
#67Enterically coated cystamine, cysteamine and derivatives thereof
#68Immediate release and sustained release ibuprofen dosing regimen
#69Polymer Composition And Dosage Forms Comprising The Same
#70Buffered coated nicotine containing products
#71MULTI-CORE DOSAGE FORM HAVING TRANSPARENT OUTER COATING
#72Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof
#73NON-HOMOGENOUS DOSAGE FORM COATINGS
#74Dosage Form Having Polymorphic Stability
#75Dosage forms having a randomized coating
#76PRESS-FIT RAPID RELEASE MEDICAMENT AND METHOD AND APPARATUS OF MANUFACTURING
#77Gelatin-based coatings having improved durability
#78SYSTEMS, METHODS AND APPARATUSES FOR MANUFACTURING DOSAGE FORMS
#79Composition for gelatin coating, gelatin coating, and preparation using the same
#80System and process for providing at least one opening in dosage forms
#81Controlled release metformin compositions
#82Modified release dosage forms
#83Controlled release opioid analgesic formulation
#84Rapidly disintegrating gelatinous coated tablets
#85Rapidly disintegrating gelatinous coated tablets
#86Systems, methods and apparatuses for manufacturing dosage forms
#87Method of treatment for improved bioavailability
#88Systems, methods and apparatuses for manufacturing dosage forms
#89Method and apparatus for transferring substrates
#90Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
#91Composite dosage forms
#92Dosage form containing a confectionery composition
#93Method of coating a dosage form comprising a first medicant